Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.
Zander M, Madsbad S, Madsen JL, Holst JJ. Zander M, et al. Lancet. 2002 Mar 9;359(9309):824-30. doi: 10.1016/S0140-6736(02)07952-7. Lancet. 2002. PMID: 11897280 Clinical Trial.
Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes.
Zander M, Taskiran M, Toft-Nielsen MB, Madsbad S, Holst JJ. Zander M, et al. Diabetes Care. 2001 Apr;24(4):720-5. doi: 10.2337/diacare.24.4.720. Diabetes Care. 2001. PMID: 11315837 Clinical Trial.
Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes.
Hermansen K, Vaaler S, Madsbad S, Dalgaard M, Zander M, Begtrup K, Soendergaard K. Hermansen K, et al. Among authors: zander m. Metabolism. 2002 Jul;51(7):896-900. doi: 10.1053/meta.2002.33358. Metabolism. 2002. PMID: 12077738 Clinical Trial.
Additive effects of glucagon-like peptide 1 and pioglitazone in patients with type 2 diabetes.
Zander M, Christiansen A, Madsbad S, Holst JJ. Zander M, et al. Diabetes Care. 2004 Aug;27(8):1910-4. doi: 10.2337/diacare.27.8.1910. Diabetes Care. 2004. PMID: 15277416 Clinical Trial.
The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes.
Zander M, Madsbad S, Deacon CF, Holst JJ. Zander M, et al. Diabetologia. 2006 Feb;49(2):369-74. doi: 10.1007/s00125-005-0098-y. Epub 2005 Dec 30. Diabetologia. 2006. PMID: 16385384 Clinical Trial.
Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes.
Højberg PV, Zander M, Vilsbøll T, Knop FK, Krarup T, Vølund A, Holst JJ, Madsbad S. Højberg PV, et al. Among authors: zander m. Diabetologia. 2008 Apr;51(4):632-40. doi: 10.1007/s00125-008-0943-x. Epub 2008 Feb 22. Diabetologia. 2008. PMID: 18292985
Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
Højberg PV, Vilsbøll T, Zander M, Knop FK, Krarup T, Vølund A, Holst JJ, Madsbad S. Højberg PV, et al. Among authors: zander m. Diabet Med. 2008 Nov;25(11):1268-75. doi: 10.1111/j.1464-5491.2008.02579.x. Diabet Med. 2008. PMID: 19046215
Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study.
Faber R, Zander M, Pena A, Michelsen MM, Mygind ND, Prescott E. Faber R, et al. Among authors: zander m. Cardiovasc Diabetol. 2015 Apr 22;14:41. doi: 10.1186/s12933-015-0206-3. Cardiovasc Diabetol. 2015. PMID: 25896352 Free PMC article. Clinical Trial.
Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.
Nilsson M, Jensen N, Gejl M, Bergmann ML, Storgaard H, Zander M, Miskowiak K, Rungby J. Nilsson M, et al. Among authors: zander m. Diabetologia. 2019 Oct;62(10):1948-1958. doi: 10.1007/s00125-019-4964-4. Epub 2019 Jul 31. Diabetologia. 2019. PMID: 31367958 Clinical Trial.
[The prevalence of type 2-diabetes in ethnic minorities].
Zander M, Hansen CR, Koefoed BG, Perrild H. Zander M, et al. Ugeskr Laeger. 2012 Sep 10;174(37):2154-8. Ugeskr Laeger. 2012. PMID: 22971296 Danish.
117 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback